UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes Journal article
FRONTIERS IN ONCOLOGY, 2019,Volume: 9
Authors:  Haotian Liao;  Wen Chen;  Yunlu Dai;  Joseph J. Richardson;  Junling Guo;  Kefei Yuan;  Yong Zeng;  Kunlin Xie
Favorite  |  View/Download:40/0  |  Submit date:2020/05/12
Programmed Cell Death-ligands  Macrophage  Tumor Immune Stroma  Tumor Microenvironment  Antipd-1 Axis Therapy  Hepatocellular Carcinoma  
Global patent landscape of programmed cell death 1: implications of the rapid expansion Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 1,Page: 69-80
Authors:  Kong, Xiangjun;  Zhang, Qianru;  Lai, Yunfeng;  Hu, Hao;  Chen, Xin;  Hu, Yuanjia
Favorite  |  View/Download:25/0  |  Submit date:2018/10/30
Programmed Cell Death 1 (Pd-1)  Patent Landscape  Patent Citation Network  Co-patent  Technology Flow  Immunotherapy  
Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy Journal article
MOLECULAR PHARMACEUTICS, 2017,Volume: 14,Issue: 11,Page: 3644-3659
Authors:  Zhang, Jinming;  Zheng, Yifeng;  Xie, Xi;  Wang, Lan;  Su, Ziren;  Wang, Yitao;  Leong, Kam W.;  Chen, Meiwan
View  |  Adobe PDF(2484Kb)  |  Favorite  |  View/Download:798/51  |  Submit date:2018/10/30
Tumor-targeting  Glycyrrhetinic Acid  Ph-sensitive  Tat Exposure  Mixed Micelles